The special topic calls for papers on tuberculosis (TB) which will appear in Advances in Natural Science as a special column.
Affiliated research area: Medical science
epidemiology, development of new diagnostics and biomarkers, development of new drugs and vaccines, public health issues related to this important pathogen
TB focuses on the characterization of TB, a pathogen that continues to create an unacceptable burden of human suffering and loss, which is overwhelmingly borne by poor and vulnerable people living in low- or middle-income countries. Progress in the global control of TB is, however, constrained by the lack of highly effective and widely accessible diagnostics, drugs and vaccines.
In addition to the Review and Original Articles by invited speakers, we are inviting you to submit a relevant research paper on Tuberculosis (TB) for consideration. Papers will be subject to normal peer review and must comply with the Guide for Authors.
To submit papers to the “Tuberculosis (TB)” Special Topic, please go to http://www.cscanada.net. Manuscripts should be submitted by the deadline written above. With your submission, please state clearly to the editor that your manuscripts are submitted to the Special Topic Tuberculosis (TB).
Tuberculosis Drug Development
Union World Conference on Lung Health
Tuberculosis Drug Development Gordon-Kenan Research Seminar
Related Journals (Special Issue):
“Tuberculosis Vaccines” Vaccines
“TB in India “Tuberculosis
“TB Meningitis Reviews” Tuberculosis
Christine F Sizemore., et al. The role of biomedical research in global tuberculosis control: gaps and challenges. Emerg Microbes Infect. 2012, 1(7): e9.
Christian Lienhardt., et al. Global tuberculosis control: lessons learnt and future prospects. Nature Reviews Microbiology 2012,10(6):407-16.